Washington, DC, United States of America

John K Simmons

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Yale University. Active years: 2017-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John K Simmons. Retrieved from https://idiyas.com/inventor/john-k-simmons

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Washington, DC (US) (2017)
Bethesda, MD (US) (2019 - 2021)

Company Filing History:

4 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2017-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11014902 - MYC G-quadruplex stabilizing small molecules and their use (2021-05-25),

2. 10604499 - MYC G-quadruplex stabilizing small molecules and their use (2020-03-31),

3. 10196372 - MYC G-quadruplex stabilizing small molecules and their use (2019-02-05),

4. 9670549 - Gene expression signatures of neoplasm responsiveness to therapy (2017-06-06),

Title: John K Simmons: Innovator in Tumor Treatment

Introduction

John K Simmons is a notable inventor based in Washington, DC. He has made significant contributions to the field of medicine, particularly in the treatment of tumors. With a total of 4 patents, his work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

One of Simmons' latest patents is titled "MYC G-quadruplex stabilizing small molecules and their use." This patent discloses methods for treating both benign and malignant tumors. The methods involve administering a therapeutically effective amount of a small molecule that selectively binds to and stabilizes G-quadruplex DNA in the promoter of the c-MYC gene. This approach is designed to decrease the size and/or number of metastases, providing a promising avenue for cancer treatment.

Career Highlights

Throughout his career, Simmons has worked with esteemed organizations, including the United States Department of Health and Human Services and Yale University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Simmons has collaborated with notable colleagues such as Beverly Mock and David Calabrese. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John K Simmons is a distinguished inventor whose work in tumor treatment showcases the potential of innovative medical solutions. His contributions continue to impact the field positively, paving the way for future advancements in cancer therapy.

Profile summary based on public USPTO records.